Medical Devices & Supplies · Medical Distributors · NSE: VIVOBIOT · data 2026-10-30
Vivo Bio Tech Ltd.
In plain words
Price: 34.5% below its 52-week high of ₹20.94.
Delivery: 73.0% of traded shares were kept for delivery over the last 10 sessions, against 81.7% over the last 52.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹55 cr |
| Net profit (last 12 months) | ₹-3 cr |
| Sales growth, 3 years (yearly) | 0.7% |
| Profit growth, 3 years (yearly) | — |
Smart-money activity
22/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 17/30: Delivery 70.6% over the last 20 sessions vs 86.5% in the 40 before (0.82x); shares delivered per day 1.87x usual; 3 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Vivo Bio Tech Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.72.
What is the 52-week high and low of Vivo Bio Tech Ltd.?
The 52-week high is ₹20.94 and the 52-week low is ₹12.
Similar companies
QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Balaxi Pharmaceuticals Limited (BALAXI) · Aakaar Medical Technologies Limited (AAKAAR) · Mono Pharmacare Limited (MONOPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open VIVOBIOT in NSE Scanner →